TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 47 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $5,362,000 | +103.1% | 5,380,000 | +100.0% | 0.03% | -25.6% |
Q3 2020 | $2,640,000 | +0.3% | 2,690,000 | 0.0% | 0.04% | -15.2% |
Q2 2020 | $2,631,000 | +4.3% | 2,690,000 | 0.0% | 0.05% | -27.0% |
Q1 2020 | $2,522,000 | -1.6% | 2,690,000 | 0.0% | 0.06% | +10.5% |
Q4 2019 | $2,562,000 | +4.6% | 2,690,000 | 0.0% | 0.06% | -16.2% |
Q3 2019 | $2,450,000 | -0.7% | 2,690,000 | 0.0% | 0.07% | +19.3% |
Q2 2019 | $2,467,000 | -1.0% | 2,690,000 | 0.0% | 0.06% | +78.1% |
Q1 2019 | $2,493,000 | – | 2,690,000 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Radcliffe Capital Management, L.P. | 70,783,000 | $69,363,000 | 6.27% |
INCOME RESEARCH & MANAGEMENT | 14,978,000 | $14,536,000 | 5.17% |
PIPER SANDLER & CO. | 5,000,000 | $4,852,000 | 3.63% |
Western Asset Management Company, LLC | 42,946,000 | $42,102,000 | 3.46% |
PenderFund Capital Management Ltd. | 4,000,000 | $5,225,000 | 1.45% |
Bracebridge Capital, LLC | 5,500,000 | $5,335,000 | 0.85% |
WESTWOOD HOLDINGS GROUP INC | 43,185,000 | $42,490,000 | 0.54% |
CORBYN INVESTMENT MANAGEMENT INC/MD | 1,025,000 | $995,000 | 0.52% |
LMR Partners LLP | 22,235,000 | $21,742,000 | 0.45% |
JUPITER ASSET MANAGEMENT LTD | 35,000,000 | $34,357,000 | 0.36% |